PALO ALTO, Californie--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq : GH), société leader en oncologie de précision, a annoncé aujourd’hui que la Food and Drug Administration (FDA) des États-Unis a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback